June 19, 2017
Follow this link to read
Date of publication: June 17
Publication type: News story
In a nutshell: Many patients with type 2 diabetes consider finger-prick blood tests key for keeping blood glucose levels under control. But according to a new study, they are unlikely to be beneficial for patients who are not receiving insulin therapy.
February 6, 2017
Source: Diabetic Medicine
Follow this link to read an abstract
Date of publication: Feb 17
Publication type: Journal article
In a nutshell: To examine the patient characteristics associated with early initiation of insulin after a diagnosis of Type 2 diabetes.
Some important notes: This article may be available via NHS Athens or through your local NHS Library. To search for your nearest library, please see http://www.hlisd.org/
June 7, 2009
Title: Switching patients from insulin glargine-based basal-bolus regimens to a once daily insulin detemir-based basal-bolus regimen: results from a subgroup of the PREDICTIVE study
Source: International Journal of Clinical Practice, 63 (3) p.425-432
Follow this link for abstract
Date of publication: 01 March 2009
Publication type: Clinical Trial
In a nutshell: The PREDICTIVE[TM] study, a large, multinational observational trial, was to evaluate the efficacy and safety of insulin detemir (IDet) in routine clinical practice. Twelve-week follow-up data from patients with type 1 (T1D) or type 2 (T2D) diabetes in the European cohort switched from once or twice daily insulin glargine (IGlarg) to qd IDet in a basal-bolus regimen. Switching from IGlarg to qd IDet was associated with improvements in glycaemic parameters and no increase in hypoglycaemic episodes or weight gain. Patients with T1D and T2D may be switched from IGlarg to qd IDet as part of a basal-bolus regimen.
Length of publication: 7 pages
Some important notes: Please contact your local NHS library for the full text of the article. Follow this link to find your local NHS library.